{"id":13556,"date":"2025-11-26T16:52:17","date_gmt":"2025-11-26T19:52:17","guid":{"rendered":"https:\/\/fenati.org.br\/?p=13556"},"modified":"2025-11-27T10:28:50","modified_gmt":"2025-11-27T13:28:50","slug":"brasil-avanca-rumo-1a-vacina-contra-dengue","status":"publish","type":"post","link":"https:\/\/homolog.fenati.org.br\/en\/brasil-avanca-rumo-1a-vacina-contra-dengue\/","title":{"rendered":"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue"},"content":{"rendered":"<p><strong>Dengue &#8211;<\/strong> A aprova\u00e7\u00e3o t\u00e9cnica da Butantan-DV marcou um passo decisivo para a chegada da primeira vacina de dose \u00fanica contra a <a href=\"https:\/\/pt.wikipedia.org\/wiki\/Dengue\" target=\"_blank\" rel=\"noopener\">dengue<\/a>. Desenvolvido pelo Instituto Butantan, o imunizante cumpriu todos os crit\u00e9rios de seguran\u00e7a, efic\u00e1cia e qualidade estabelecidos pela Anvisa e segue agora para a formaliza\u00e7\u00e3o administrativa do registro. Ap\u00f3s essa etapa, caber\u00e1 ao Minist\u00e9rio da Sa\u00fade definir como ser\u00e1 sua incorpora\u00e7\u00e3o ao Programa Nacional de Imuniza\u00e7\u00f5es (PNI).<\/p>\n<p>A assinatura do Termo de Compromisso entre a ag\u00eancia reguladora e o instituto, realizada em S\u00e3o Paulo, simboliza o \u00faltimo movimento antes da publica\u00e7\u00e3o oficial. Mesmo sem data definida para a inclus\u00e3o no calend\u00e1rio vacinal, o avan\u00e7o j\u00e1 permite que o governo organize estrat\u00e9gias de distribui\u00e7\u00e3o e log\u00edstica.<\/p>\n<p><a href=\"https:\/\/fenati.org.br\/levar-celular-banheiro-eleva-chances-hemorroidas\/\" target=\"_blank\" rel=\"noopener\"><strong>LEIA: H\u00e1bito de levar o celular ao banheiro eleva chances de hemorroidas<\/strong><\/a><\/p>\n<p>O Butantan iniciou a fabrica\u00e7\u00e3o da vacina antes mesmo da conclus\u00e3o da an\u00e1lise regulat\u00f3ria. Atualmente, mais de 1 milh\u00e3o de doses est\u00e3o prontas para serem disponibilizadas ao PNI. Para ampliar a oferta, o instituto tamb\u00e9m estabeleceu parceria com a empresa chinesa WuXi, o que deve garantir 30 milh\u00f5es de doses no segundo semestre de 2026.<\/p>\n<p>O pediatra e infectologista Renato Kfouri, vice-presidente da Sociedade Brasileira de Imuniza\u00e7\u00f5es (SBIm), destaca a efic\u00e1cia demonstrada nos estudos cl\u00ednicos. Segundo ele, a vacina apresentou cerca de 75% de prote\u00e7\u00e3o geral e mais de 90% contra casos graves e hospitaliza\u00e7\u00f5es. Ele tamb\u00e9m ressalta a vantagem estrat\u00e9gica da produ\u00e7\u00e3o nacional, que facilita a escala de distribui\u00e7\u00e3o.<\/p>\n<p><strong>Resultados dos estudos cl\u00ednicos<\/strong><\/p>\n<p>A decis\u00e3o da Anvisa foi baseada em cinco anos de acompanhamento de volunt\u00e1rios na fase 3 do estudo. Entre participantes de 12 a 59 anos, os dados mostraram:<\/p>\n<p>\u2022 Efic\u00e1cia geral: 74,7%<br \/>\n\u2022 Prote\u00e7\u00e3o contra formas graves ou com sinais de alarme: 91,6%<br \/>\n\u2022 Prote\u00e7\u00e3o contra hospitaliza\u00e7\u00f5es: 100%<\/p>\n<p>O ensaio envolveu mais de 16 mil volunt\u00e1rios de 14 estados brasileiros, com monitoramento entre 2016 e 2024. A vacina quadrivalente se mostrou segura tanto para pessoas que j\u00e1 tiveram dengue quanto para aquelas que nunca tiveram contato com o v\u00edrus.<\/p>\n<p>Segundo Kfouri, a prote\u00e7\u00e3o se manteve ao longo de mais de cinco anos ap\u00f3s uma \u00fanica aplica\u00e7\u00e3o. As rea\u00e7\u00f5es registradas foram majoritariamente leves ou moderadas, como dor local, vermelhid\u00e3o, fadiga e dor de cabe\u00e7a. Casos mais intensos foram incomuns e tiveram recupera\u00e7\u00e3o completa.<\/p>\n<p><strong>Impacto da dose \u00fanica<\/strong><\/p>\n<p>A Butantan-DV inaugura no cen\u00e1rio mundial a possibilidade de imuniza\u00e7\u00e3o contra dengue com apenas uma aplica\u00e7\u00e3o. Relat\u00f3rios cient\u00edficos apontam que vacinas de dose \u00fanica tendem a facilitar campanhas, aumentar a ades\u00e3o e acelerar a cobertura populacional \u2014 especialmente em situa\u00e7\u00f5es de alta circula\u00e7\u00e3o do v\u00edrus.<\/p>\n<p>Para Kfouri, o desempenho do imunizante brasileiro se aproxima ao de outras vacinas j\u00e1 dispon\u00edveis, com o diferencial da aplica\u00e7\u00e3o \u00fanica como principal vantagem. A Anvisa tamb\u00e9m autorizou estudos para ampliar o uso em pessoas de 60 a 79 anos, enquanto a faixa de 2 a 11 anos ainda est\u00e1 em an\u00e1lise.<\/p>\n<p>Com a parte t\u00e9cnica conclu\u00edda e a produ\u00e7\u00e3o em andamento, o Minist\u00e9rio da Sa\u00fade deve definir quando a vacina\u00e7\u00e3o come\u00e7ar\u00e1 e como ser\u00e1 organizada a distribui\u00e7\u00e3o das doses. A expectativa \u00e9 que a Butantan-DV se torne um novo refor\u00e7o no enfrentamento do aumento de casos de dengue no pa\u00eds<\/p>\n<p><em><strong>(Com informa\u00e7\u00f5es de Olhar Digital)<\/strong><\/em><br \/>\n<em><strong>(Foto: Reprodu\u00e7\u00e3o\/Freepik)<\/strong><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Imunizante desenvolvido pelo Instituto Butantan tem produ\u00e7\u00e3o nacional e mais de 1 milh\u00e3o de doses j\u00e1 em estoque<\/p>","protected":false},"author":6,"featured_media":13557,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[13],"class_list":["post-13556","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-sindical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue - FENATI<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue - FENATI\" \/>\n<meta property=\"og:description\" content=\"Imunizante desenvolvido pelo Instituto Butantan tem produ\u00e7\u00e3o nacional e mais de 1 milh\u00e3o de doses j\u00e1 em estoque\" \/>\n<meta property=\"og:url\" content=\"https:\/\/homolog.fenati.org.br\/en\/brasil-avanca-rumo-1a-vacina-contra-dengue\/\" \/>\n<meta property=\"og:site_name\" content=\"FENATI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/feittinf\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-26T19:52:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-27T13:28:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2025\/11\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pixel Desenvolvimento\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FederacaoTiBR\" \/>\n<meta name=\"twitter:site\" content=\"@FederacaoTiBR\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pixel Desenvolvimento\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/\"},\"author\":{\"name\":\"Pixel Desenvolvimento\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#\\\/schema\\\/person\\\/c5452475dc8a2840f9d7c9952837cbae\"},\"headline\":\"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue\",\"datePublished\":\"2025-11-26T19:52:17+00:00\",\"dateModified\":\"2025-11-27T13:28:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/\"},\"wordCount\":600,\"publisher\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg\",\"keywords\":[\"sindical\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/\",\"name\":\"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue - FENATI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg\",\"datePublished\":\"2025-11-26T19:52:17+00:00\",\"dateModified\":\"2025-11-27T13:28:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/#primaryimage\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg\",\"contentUrl\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg\",\"width\":1200,\"height\":630,\"caption\":\"brasil-avanca-rumo-1a-vacina-contra-dengue\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/brasil-avanca-rumo-1a-vacina-contra-dengue\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/homolog.fenati.org.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#website\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/\",\"name\":\"FEITTINF\",\"description\":\"Federa\u00e7\u00e3o Nacional dos Trabalhadores em Tecnologia da\u00a0Informa\u00e7\u00e3o\",\"publisher\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/homolog.fenati.org.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#organization\",\"name\":\"FEITTINF\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/logo_300x50.png\",\"contentUrl\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/logo_300x50.png\",\"width\":350,\"height\":50,\"caption\":\"FEITTINF\"},\"image\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/feittinf\",\"https:\\\/\\\/x.com\\\/FederacaoTiBR\",\"https:\\\/\\\/www.instagram.com\\\/feittinf\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#\\\/schema\\\/person\\\/c5452475dc8a2840f9d7c9952837cbae\",\"name\":\"Pixel Desenvolvimento\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/en\\\/author\\\/suporte-pixel\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue - FENATI","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue - FENATI","og_description":"Imunizante desenvolvido pelo Instituto Butantan tem produ\u00e7\u00e3o nacional e mais de 1 milh\u00e3o de doses j\u00e1 em estoque","og_url":"https:\/\/homolog.fenati.org.br\/en\/brasil-avanca-rumo-1a-vacina-contra-dengue\/","og_site_name":"FENATI","article_publisher":"https:\/\/www.facebook.com\/feittinf","article_published_time":"2025-11-26T19:52:17+00:00","article_modified_time":"2025-11-27T13:28:50+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2025\/11\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg","type":"image\/jpeg"}],"author":"Pixel Desenvolvimento","twitter_card":"summary_large_image","twitter_creator":"@FederacaoTiBR","twitter_site":"@FederacaoTiBR","twitter_misc":{"Written by":"Pixel Desenvolvimento","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/#article","isPartOf":{"@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/"},"author":{"name":"Pixel Desenvolvimento","@id":"https:\/\/homolog.fenati.org.br\/#\/schema\/person\/c5452475dc8a2840f9d7c9952837cbae"},"headline":"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue","datePublished":"2025-11-26T19:52:17+00:00","dateModified":"2025-11-27T13:28:50+00:00","mainEntityOfPage":{"@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/"},"wordCount":600,"publisher":{"@id":"https:\/\/homolog.fenati.org.br\/#organization"},"image":{"@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/#primaryimage"},"thumbnailUrl":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2025\/11\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg","keywords":["sindical"],"articleSection":["Not\u00edcias"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/","url":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/","name":"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue - FENATI","isPartOf":{"@id":"https:\/\/homolog.fenati.org.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/#primaryimage"},"image":{"@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/#primaryimage"},"thumbnailUrl":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2025\/11\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg","datePublished":"2025-11-26T19:52:17+00:00","dateModified":"2025-11-27T13:28:50+00:00","breadcrumb":{"@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/#primaryimage","url":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2025\/11\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg","contentUrl":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2025\/11\/brasil-avanca-rumo-1a-vacina-contra-dengue.jpg","width":1200,"height":630,"caption":"brasil-avanca-rumo-1a-vacina-contra-dengue"},{"@type":"BreadcrumbList","@id":"https:\/\/homolog.fenati.org.br\/brasil-avanca-rumo-1a-vacina-contra-dengue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/homolog.fenati.org.br\/"},{"@type":"ListItem","position":2,"name":"Brasil avan\u00e7a rumo \u00e0 1\u00aa vacina de aplica\u00e7\u00e3o \u00fanica contra a dengue"}]},{"@type":"WebSite","@id":"https:\/\/homolog.fenati.org.br\/#website","url":"https:\/\/homolog.fenati.org.br\/","name":"FEITTINF","description":"Federa\u00e7\u00e3o Nacional dos Trabalhadores em Tecnologia da\u00a0Informa\u00e7\u00e3o","publisher":{"@id":"https:\/\/homolog.fenati.org.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/homolog.fenati.org.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/homolog.fenati.org.br\/#organization","name":"FEITTINF","url":"https:\/\/homolog.fenati.org.br\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/homolog.fenati.org.br\/#\/schema\/logo\/image\/","url":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2023\/08\/logo_300x50.png","contentUrl":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2023\/08\/logo_300x50.png","width":350,"height":50,"caption":"FEITTINF"},"image":{"@id":"https:\/\/homolog.fenati.org.br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/feittinf","https:\/\/x.com\/FederacaoTiBR","https:\/\/www.instagram.com\/feittinf\/"]},{"@type":"Person","@id":"https:\/\/homolog.fenati.org.br\/#\/schema\/person\/c5452475dc8a2840f9d7c9952837cbae","name":"Pixel Desenvolvimento","url":"https:\/\/homolog.fenati.org.br\/en\/author\/suporte-pixel\/"}]}},"_links":{"self":[{"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/posts\/13556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/comments?post=13556"}],"version-history":[{"count":1,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/posts\/13556\/revisions"}],"predecessor-version":[{"id":13558,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/posts\/13556\/revisions\/13558"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/media\/13557"}],"wp:attachment":[{"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/media?parent=13556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/categories?post=13556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/tags?post=13556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}